Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-05-09FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Lifestar Pharma LLC)
FDA approved a supplemental application for nicardipine hydrochloride from Lifestar Pharma LLC, indicating a change under an approved ANDA.
-
FDA approval · 2025-05-06FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from Mylan Pharmaceuticals Inc., enabling continued marketing of the…
-
FDA approval · 2025-04-17FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for Nicardipine hydrochloride from Epic Pharma, LLC, under the ANDA process. This represents a s…
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental NDA for the extended-release form of diltiazem hydrochloride.
-
FDA approval · 2025-04-16FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Cardizem LA (diltiazem hydrochloride extended-release) submitted by Bausch Health US LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-16FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride by Oceanside Pharmaceuticals.
-
FDA approval · 2025-04-15FDA Approved: NITROGLYCERIN — Original Application (Encube Ethicals, Inc.)
FDA approves Encube Ethicals, Inc.'s nitroglycerin product under an Original Application (ANDA). This expands access to a generic nitroglyce…
-
FDA approval · 2025-03-28FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Cipla USA Inc.)
The FDA approved a supplemental application for nicardipine hydrochloride from Cipla USA Inc., indicating an update to this generic product'…
-
FDA approval · 2025-03-24FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for metoprolol tartrate by Hikma Pharmaceuticals USA Inc. (ANDA 077761), updating the regulatory sta…
-
FDA approval · 2025-03-17FDA Approved: ATENOLOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Atenolol from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2025-03-07FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (TruPharma LLC)
FDA approved a supplemental application for Bisoprolol Fumarate from TruPharma LLC, validating the generic product under ANDA075643.
-
FDA approval · 2025-02-21FDA Approved: DILTIAZEM HYDROCHLORIDE IN SODIUM CHLORIDE — Original Application (WG Critical Care, LLC)
FDA approved a new injectable diltiazem hydrochloride in sodium chloride under an original NDA from WG Critical Care, LLC. This parenteral f…
-
FDA approval · 2025-01-08FDA Approved: ISOSORBIDE DINITRATE — Supplemental Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s supplemental application for Isosorbide Dinitrate, indicating an approved modification to the generic product …
-
FDA approval · 2025-01-03FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for amlodipine besylate from Ascend Laboratories, LLC. Amlodipine besylate is a generic calcium chan…
-
FDA approval · 2024-12-23FDA Approved: FELODIPINE — Supplemental Application (Carlsbad Technology, Inc.)
FDA approved a supplemental application for Felodipine from Carlsbad Technology, Inc., indicating an update to the drug's regulatory status …
-
FDA approval · 2024-12-16FDA Approved: NITROGLYCERIN — Original Application (Encube Ethicals, Inc.)
The FDA approved Encube Ethicals, Inc.'s generic nitroglycerin product under an Original Application (ANDA216452). This approval provides a …
-
FDA approval · 2024-11-12FDA Approved: METOPROLOL — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for metoprolol tartrate (metoprolol) from Baxter Healthcare Corporation. This document indicates the…
-
FDA approval · 2024-11-08FDA Approved: IVABRADINE — Original Application (Alembic Pharmaceuticals Limited)
The FDA approved Alembic Pharmaceuticals Limited's original application for a generic IVABRADINE product.
-
FDA approval · 2024-10-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' generic diltiazem hydrochloride under an Original Application (ANDA).
-
FDA approval · 2024-09-25FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for metoprolol tartrate (metoprolol) under ANDA 202871, enabling a generic ve…
-
FDA approval · 2024-09-24FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s generic nicardipine hydrochloride (ANDA Original Application). Nicardipine hydrochloride is a calcium channel …
-
FDA approval · 2024-09-12FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for diltiazem hydrochloride by Mylan Pharmaceuticals Inc. under ANDA074910, indicating regulatory ap…
-
FDA approval · 2024-09-09FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for Verapamil Hydrochloride (Hospira, Inc.), confirming it as an approved generic drug under an ANDA…
-
FDA approval · 2024-09-06FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Chengdu Shuode Pharmaceutical Co., Ltd)
FDA approved nicardipine hydrochloride as an original-application product from Chengdu Shuode Pharmaceutical Co., Ltd.
-
EMA approval · 2024-09-06EMA Authorised: Ivabradine Accord (ivabradine hydrochloride) — Accord Healthcare S.L.U.
The EMA authorised Ivabradine Accord (ivabradine hydrochloride) from Accord Healthcare S.L.U. for the treatment of angina pectoris and heart…